CRESUD (CRESY) director boosts stake with 17,000 ADS open-market buy

Rhea-AI Filing Summary

CRESUD INC director Saul Zang reported buying 17,000 American Depositary Shares in an open-market transaction. He paid an average price of $10.6343 per ADS. After this purchase, he directly owns 334,720 ADS, indicating he increased his personal stake in the company through this single transaction.

Insider Trade Summary

Net Buyer: 17,000 shares ($180,783)

Net Buy 1 txn

Insider Zang Saul

Role null

Bought 17,000 shs ($181K)

Type	Security	Shares	Price	Value
Purchase	American Depositary Shares (ADS)	17,000	$10.6343	$181K

Holdings After Transaction: American Depositary Shares (ADS) — 334,720 shares (Direct, null)

Footnotes (1)

Key Figures

Shares purchased: 17,000 ADS Purchase price: $10.6343 per ADS Post-transaction holdings: 334,720 ADS +1 more

4 metrics

Shares purchased 17,000 ADS Open-market purchase reported on Form 4

Purchase price $10.6343 per ADS Average price for the reported transaction

Post-transaction holdings 334,720 ADS Direct ownership after the purchase

Net buy shares 17,000 ADS Net change in non-derivative position from this filing

Key Terms

American Depositary Shares (ADS), open-market purchase, Form 4, non-derivative

4 terms

American Depositary Shares (ADS) financial

"security_title: "American Depositary Shares (ADS)""

American depositary shares (ADS) are a way for investors in the United States to buy shares of foreign companies without dealing with the complexities of international markets. They represent ownership in a foreign company's stock and are traded on U.S. exchanges, making it easier and more convenient for Americans to invest internationally. ADSs allow investors to diversify their portfolios with foreign companies while using familiar trading platforms.

open-market purchase financial

"transaction_action: "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

non-derivative financial

"transaction_type: "non-derivative""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zang Saul

(Last) (First) (Middle)

AV EDUARDO MADERO 942

25TH FLOOR

(Street)

BUENOS AIRES C1106ACW

(City) (State) (Zip)

ARGENTINA

(Country)

2. Issuer Name and Ticker or Trading Symbol
CRESUD INC [ CRESY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol
[CRES]

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
American Depositary Shares (ADS)	05/20/2026		P		17,000	A	$10.6343	334,720	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Marcos Slipakoff by P.O.A. for Saul Zang	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CRESUD INC (CRESY) disclose in this Form 4?

CRESUD INC director Saul Zang disclosed an open-market purchase of 17,000 American Depositary Shares. The transaction was reported on Form 4 and reflects a personal investment, expanding his direct ownership position in the company’s ADSs.

At what price did Saul Zang buy CRESUD INC ADS shares?

Saul Zang purchased 17,000 American Depositary Shares at an average price of $10.6343 per ADS. This figure represents the weighted average price paid for the reported transaction on the trade date shown in the Form 4 filing.

How many CRESUD INC shares does Saul Zang own after this transaction?

Following the reported purchase, Saul Zang directly owns 334,720 American Depositary Shares of CRESUD INC. This post-transaction holding amount is disclosed in the Form 4 as his total direct ownership after the open-market buy.

Was the CRESUD INC Form 4 transaction a buy or a sell?

The Form 4 reports a buy transaction. Specifically, it shows an open-market purchase coded as “P,” with 17,000 American Depositary Shares acquired by director Saul Zang, increasing his directly held position in CRESUD INC.

Does the CRESUD INC Form 4 involve derivative securities or only ADS?

This Form 4 involves only non-derivative securities, specifically American Depositary Shares of CRESUD INC. The derivative section is empty, indicating no options, warrants, or other derivative instruments were reported in this particular insider transaction.